Charles Schoch - Interim Chief Financial Officer at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim Chief Financial Officer
Stock Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Charles Schoch - trading volume in the past year for Candel Therapeutics, Inc.

Holdings reported by Charles Schoch for Candel Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 62.5K $405K $6.47 Jul 17, 2024 Direct

Transactions reported by Charles Schoch for Candel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.